{"count": 15, "results": [{"_id": "37381964", "pmid": 37381964, "title": "[Compound Tinglizi Decoction intervenes COPD-associated pulmonary hypertension through regulation of HMGB1-mediated pyroptosis and immune imbalance].", "journal": "Zhongguo Zhong Yao Za Zhi", "authors": ["Wu XC", "Liu Y", "Bai ZP"], "date": "2023-06-01T00:00:00Z", "doi": "10.19540/j.cnki.cjcmm.20221014.702", "meta_date_publication": "2023 Jun", "meta_volume": "48", "meta_issue": "11", "meta_pages": "3055-3065", "score": 50236.465, "text_hl": "Rats in the low, medium, and high-dose Compound Tinglizi Decoction groups were given 4.93, 9.87, and 19.74 g kg~(-1) Compound Tinglizi Decoction by gavage, respectively. Rats in the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ group were given 1.50 mg kg~(-1) @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ by gavage. ", "citations": {"NLM": "Wu XC, Liu Y, Bai ZP. [Compound Tinglizi Decoction intervenes COPD-associated pulmonary hypertension through regulation of HMGB1-mediated pyroptosis and immune imbalance]. Zhongguo Zhong Yao Za Zhi. 2023 Jun;48(11):3055-3065. PMID: 37381964", "BibTeX": "@article{37381964, title={[Compound Tinglizi Decoction intervenes COPD-associated pulmonary hypertension through regulation of HMGB1-mediated pyroptosis and immune imbalance].}, author={Wu XC and Liu Y and Bai ZP}, journal={Zhongguo Zhong Yao Za Zhi}, volume={48}, number={11}, pages={3055-3065}}"}}, {"_id": "16698853", "pmid": 16698853, "title": "Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension.", "journal": "Am J Physiol Lung Cell Mol Physiol", "authors": ["Taraseviciene-Stewart L", "Scerbavicius R", "Choe KH", "Cool C", "Wood K", "Tuder RM", "Burns N", "Kasper M", "Voelkel NF"], "date": "2006-10-01T00:00:00Z", "doi": "10.1152/ajplung.00491.2005", "meta_date_publication": "2006 Oct", "meta_volume": "291", "meta_issue": "4", "meta_pages": "L668-76", "score": 50070.754, "text_hl": "In contrast, treatment of @SPECIES_10116 @@@rats@@@ with established @DISEASE_Severe_Acute_Respiratory_Syndrome @DISEASE_MESH:D045169 @@@SPH@@@ with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ markedly reduced mean PAP and @<m>DISEASE_Hypertrophy_Right_Ventricular</m> @DISEASE_MESH:D017380 @@@right ventricular hypertrophy@@@, and this reduction was associated with @GENE_CASP3 @GENE_25402 @@@caspase-3@@@ activation and pulmonary microvascular endothelial cell apoptosis. ", "citations": {"NLM": "Taraseviciene-Stewart L, Scerbavicius R, Choe KH, Cool C, Wood K, Tuder RM, Burns N, Kasper M, Voelkel NF. Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2006 Oct;291(4):L668-76. PMID: 16698853", "BibTeX": "@article{16698853, title={Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension.}, author={Taraseviciene-Stewart L and Scerbavicius R and Choe KH and Cool C and Wood K and Tuder RM and Burns N and Kasper M and Voelkel NF}, journal={Am J Physiol Lung Cell Mol Physiol}, volume={291}, number={4}, pages={L668-76}}"}}, {"_id": "31369604", "pmid": 31369604, "pmcid": "PMC6675113", "title": "Simvastatin causes pulmonary artery relaxation by blocking smooth muscle ROCK and calcium channels: Evidence for an endothelium-independent mechanism", "journal": "PLoS One", "authors": ["Absi M", "Eid BG", "Ashton N", "Hart G", "Gurney AM"], "date": "2019-08-01T00:00:00Z", "doi": "10.1371/journal.pone.0220473", "meta_date_publication": "2019", "meta_volume": "14", "meta_issue": "8", "meta_pages": "e0220473", "score": 50067.953, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ reduces pulmonary arterial pressure and @<m>DISEASE_Hypertrophy_Right_Ventricular</m> @DISEASE_MESH:D017380 @@@right ventricular hypertrophy@@@ in animal models of @DISEASE_Pulmonary_Arterial_Hypertension @DISEASE_MESH:D000081029 @@@pulmonary arterial hypertension@@@ (@DISEASE_Pulmonary_Arterial_Hypertension @DISEASE_MESH:D000081029 @@@PAH@@@) and is thought to restore endothelial dysfunction. ", "citations": {"NLM": "Absi M, Eid BG, Ashton N, Hart G, Gurney AM. Simvastatin causes pulmonary artery relaxation by blocking smooth muscle ROCK and calcium channels: Evidence for an endothelium-independent mechanism PLoS One. 2019;14(8):e0220473. PMID: 31369604", "BibTeX": "@article{31369604, title={Simvastatin causes pulmonary artery relaxation by blocking smooth muscle ROCK and calcium channels: Evidence for an endothelium-independent mechanism}, author={Absi M and Eid BG and Ashton N and Hart G and Gurney AM}, journal={PLoS One}, volume={14}, number={8}, pages={e0220473}}"}}, {"_id": "12406854", "pmid": 12406854, "title": "Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.", "journal": "Am J Respir Crit Care Med", "authors": ["Nishimura T", "Faul JL", "Berry GJ", "Vaszar LT", "Qiu D", "Pearl RG", "Kao PN"], "date": "2002-11-15T00:00:00Z", "doi": "10.1164/rccm.200203-268OC", "meta_date_publication": "2002 Nov 15", "meta_volume": "166", "meta_issue": "10", "meta_pages": "1403-8", "score": 50065.734, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ attenuates @CHEMICAL_Monocrotaline @CHEMICAL_MESH:D016686 @@@monocrotaline@@@-induced pulmonary vascular remodeling with neointimal formation, @DISEASE_Pulmonary_Arterial_Hypertension @DISEASE_MESH:D000081029 @@@pulmonary arterial hypertension@@@, and @<m>DISEASE_Hypertrophy_Right_Ventricular</m> @DISEASE_MESH:D017380 @@@right ventricular hypertrophy@@@ in @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Nishimura T, Faul JL, Berry GJ, Vaszar LT, Qiu D, Pearl RG, Kao PN. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats. Am J Respir Crit Care Med. 2002 Nov 15;166(10):1403-8. PMID: 12406854", "BibTeX": "@article{12406854, title={Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats.}, author={Nishimura T and Faul JL and Berry GJ and Vaszar LT and Qiu D and Pearl RG and Kao PN}, journal={Am J Respir Crit Care Med}, volume={166}, number={10}, pages={1403-8}}"}}, {"_id": "20460548", "pmid": 20460548, "title": "Simvastatin as a treatment for pulmonary hypertension trial.", "journal": "Am J Respir Crit Care Med", "authors": ["Wilkins MR", "Ali O", "Bradlow W", "Wharton J", "Taegtmeyer A", "Rhodes CJ", "Ghofrani HA", "Howard L", "Nihoyannopoulos P", "Mohiaddin RH", "Gibbs JS", "Simvastatin Pulmonary Hypertension Trial (SiPHT) Study Group"], "date": "2010-05-15T00:00:00Z", "doi": "10.1164/rccm.2009111-699oc", "meta_date_publication": "2010 May 15", "meta_volume": "181", "meta_issue": "10", "meta_pages": "1106-13", "score": 50065.582, "text_hl": "RATIONALE: In animal models of @DISEASE_Hypertension_Pulmonary @DISEASE_MESH:D006976 @@@pulmonary hypertension@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ has been shown to reduce pulmonary artery pressure and induce regression of associated @<m>DISEASE_Hypertrophy_Right_Ventricular</m> @DISEASE_MESH:D017380 @@@right ventricular (RV) hypertrophy@@@. ", "citations": {"NLM": "Wilkins MR, Ali O, Bradlow W, Wharton J, Taegtmeyer A, Rhodes CJ, Ghofrani HA, Howard L, Nihoyannopoulos P, Mohiaddin RH, Gibbs JS, Simvastatin Pulmonary Hypertension Trial (SiPHT) Study Group. Simvastatin as a treatment for pulmonary hypertension trial. Am J Respir Crit Care Med. 2010 May 15;181(10):1106-13. PMID: 20460548", "BibTeX": "@article{20460548, title={Simvastatin as a treatment for pulmonary hypertension trial.}, author={Wilkins MR and Ali O and Bradlow W and Wharton J and Taegtmeyer A and Rhodes CJ and Ghofrani HA and Howard L and Nihoyannopoulos P and Mohiaddin RH and Gibbs JS and Simvastatin Pulmonary Hypertension Trial (SiPHT) Study Group}, journal={Am J Respir Crit Care Med}, volume={181}, number={10}, pages={1106-13}}"}}, {"_id": "22022327", "pmid": 22022327, "pmcid": "PMC3193043", "title": "Changes of Pulmonary Pathology and Gene Expressions After Simvastatin Treatment in the Monocrotaline-Induced Pulmonary Hypertension Rat Model", "journal": "Korean Circ J", "authors": ["Lee YH", "Kim KC", "Cho MS", "Hong YM"], "date": "2011-09-01T00:00:00Z", "doi": "10.4070/kcj.2011.41.9.518", "meta_date_publication": "2011 Sep", "meta_volume": "41", "meta_issue": "9", "meta_pages": "518-27", "score": 50064.785, "text_hl": "...On day 28, @<m>DISEASE_Hypertrophy_Right_Ventricular</m> @DISEASE_MESH:D017380 @@@right ventricular hypertrophy@@@ (@<m>DISEASE_Hypertrophy_Right_Ventricular</m> @DISEASE_MESH:D017380 @@@RVH@@@) significantly decreased in the @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ group compared to the M group. ", "citations": {"NLM": "Lee YH, Kim KC, Cho MS, Hong YM. Changes of Pulmonary Pathology and Gene Expressions After Simvastatin Treatment in the Monocrotaline-Induced Pulmonary Hypertension Rat Model Korean Circ J. 2011 Sep;41(9):518-27. PMID: 22022327", "BibTeX": "@article{22022327, title={Changes of Pulmonary Pathology and Gene Expressions After Simvastatin Treatment in the Monocrotaline-Induced Pulmonary Hypertension Rat Model}, author={Lee YH and Kim KC and Cho MS and Hong YM}, journal={Korean Circ J}, volume={41}, number={9}, pages={518-27}}"}}, {"_id": "20188205", "pmid": 20188205, "title": "Combination of sildenafil and simvastatin ameliorates monocrotaline-induced pulmonary hypertension in rats.", "journal": "Pulm Pharmacol Ther", "authors": ["Kuang T", "Wang J", "Pang B", "Huang X", "Burg ED", "Yuan JX", "Wang C"], "date": "2010-10-01T00:00:00Z", "doi": "10.1016/j.pupt.2010.02.003", "meta_date_publication": "2010 Oct", "meta_volume": "23", "meta_issue": "5", "meta_pages": "456-64", "score": 50064.582, "text_hl": "Combination @CHEMICAL_Sildenafil_Citrate @CHEMICAL_MESH:D000068677 @@@sildenafil@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment prevented the @CHEMICAL_SMOFlipid @CHEMICAL_MESH:C000709826 @@@MCT@@@-induced increases in right ventricular systolic pressure (RVSP) and @<m>DISEASE_Hypertrophy_Right_Ventricular</m> @DISEASE_MESH:D017380 @@@right ventricular hypertrophy@@@ (@<m>DISEASE_Hypertrophy_Right_Ventricular</m> @DISEASE_MESH:D017380 @@@RVH@@@), exerted an anti-proliferative effect on pulmonary artery smooth muscle cells (PASMC). ", "citations": {"NLM": "Kuang T, Wang J, Pang B, Huang X, Burg ED, Yuan JX, Wang C. Combination of sildenafil and simvastatin ameliorates monocrotaline-induced pulmonary hypertension in rats. Pulm Pharmacol Ther. 2010 Oct;23(5):456-64. PMID: 20188205", "BibTeX": "@article{20188205, title={Combination of sildenafil and simvastatin ameliorates monocrotaline-induced pulmonary hypertension in rats.}, author={Kuang T and Wang J and Pang B and Huang X and Burg ED and Yuan JX and Wang C}, journal={Pulm Pharmacol Ther}, volume={23}, number={5}, pages={456-64}}"}}, {"_id": "19797670", "pmid": 19797670, "title": "Simvastatin and sildenafil combine to attenuate pulmonary hypertension.", "journal": "Eur Respir J", "authors": ["Zhao L", "Sebkhi A", "Ali O", "Wojciak-Stothard B", "Mamanova L", "Yang Q", "Wharton J", "Wilkins MR"], "date": "2009-10-01T00:00:00Z", "doi": "10.1183/09031936.00143508", "meta_date_publication": "2009 Oct", "meta_volume": "34", "meta_issue": "4", "meta_pages": "948-57", "score": 50062.156, "text_hl": "In both protocols, the combination of @CHEMICAL_Sildenafil_Citrate @CHEMICAL_MESH:D000068677 @@@sildenafil@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ lowered pulmonary artery pressure and produced a significantly greater reduction in @<m>DISEASE_Hypertrophy_Right_Ventricular</m> @DISEASE_MESH:D017380 @@@right ventricular hypertrophy@@@ and pulmonary vascular muscularisation than either drug alone. ", "citations": {"NLM": "Zhao L, Sebkhi A, Ali O, Wojciak-Stothard B, Mamanova L, Yang Q, Wharton J, Wilkins MR. Simvastatin and sildenafil combine to attenuate pulmonary hypertension. Eur Respir J. 2009 Oct;34(4):948-57. PMID: 19797670", "BibTeX": "@article{19797670, title={Simvastatin and sildenafil combine to attenuate pulmonary hypertension.}, author={Zhao L and Sebkhi A and Ali O and Wojciak-Stothard B and Mamanova L and Yang Q and Wharton J and Wilkins MR}, journal={Eur Respir J}, volume={34}, number={4}, pages={948-57}}"}}, {"_id": "19409105", "pmid": 19409105, "pmcid": "PMC2681458", "title": "Simvastatin ameliorates established pulmonary hypertension through a heme oxygenase-1 dependent pathway in rats", "journal": "Respir Res", "authors": ["Hsu HH", "Ko WJ", "Hsu JY", "Chen JS", "Lee YC", "Lai IR", "Chen CF"], "date": "2009-05-02T00:00:00Z", "doi": "10.1186/1465-9921-10-32", "meta_date_publication": "2009 May 2", "meta_volume": "10", "meta_issue": "1", "meta_pages": "32", "score": 50061.617, "text_hl": "SnPP Suppressed the Ameliorative Effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ on @<m>DISEASE_Hypertrophy_Right_Ventricular</m> @DISEASE_MESH:D017380 @@@RVH@@@", "citations": {"NLM": "Hsu HH, Ko WJ, Hsu JY, Chen JS, Lee YC, Lai IR, Chen CF. Simvastatin ameliorates established pulmonary hypertension through a heme oxygenase-1 dependent pathway in rats Respir Res. 2009 May 2;10(1):32. PMID: 19409105", "BibTeX": "@article{19409105, title={Simvastatin ameliorates established pulmonary hypertension through a heme oxygenase-1 dependent pathway in rats}, author={Hsu HH and Ko WJ and Hsu JY and Chen JS and Lee YC and Lai IR and Chen CF}, journal={Respir Res}, volume={10}, number={1}, pages={32}}"}}, {"_id": "25560572", "pmid": 25560572, "title": "HMG-COA reductase inhibitors: An opportunity for the improvement of imatinib safety. An experimental study in rat pulmonary hypertension.", "journal": "Pharmacol Rep", "authors": ["Jasińska-Stroschein M", "Owczarek J", "Surowiecka A", "Kącikowska J", "Orszulak-Michalak D"], "date": "2015-02-01T00:00:00Z", "doi": "10.1016/j.pharep.2014.07.011", "meta_date_publication": "2015 Feb", "meta_volume": "67", "meta_issue": "1", "meta_pages": "32-7", "score": 50056.367, "text_hl": "METHODS: The effects of imanitib at dose of 20 and 50mg/kg bw given together with @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ or @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ were investigated with respect to right ventricle pressure (RVP), arterial blood pressure and @<m>DISEASE_Hypertrophy_Right_Ventricular</m> @DISEASE_MESH:D017380 @@@right ventricle hypertrophy@@@ (@<m>DISEASE_Hypertrophy_Right_Ventricular</m> @DISEASE_MESH:D017380 @@@RVH@@@) in experimental @CHEMICAL_Monocrotaline @CHEMICAL_MESH:D016686 @@@monocrotaline@@@ (@CHEMICAL_Monocrotaline @CHEMICAL_MESH:D016686 @@@MCT@@@)-induced @DISEASE_Hypertension_Pulmonary @DISEASE_MESH:D006976 @@@pulmonary hypertension@@@. ", "citations": {"NLM": "Jasińska-Stroschein M, Owczarek J, Surowiecka A, Kącikowska J, Orszulak-Michalak D. HMG-COA reductase inhibitors: An opportunity for the improvement of imatinib safety. An experimental study in rat pulmonary hypertension. Pharmacol Rep. 2015 Feb;67(1):32-7. PMID: 25560572", "BibTeX": "@article{25560572, title={HMG-COA reductase inhibitors: An opportunity for the improvement of imatinib safety. An experimental study in rat pulmonary hypertension.}, author={Jasińska-Stroschein M and Owczarek J and Surowiecka A and Kącikowska J and Orszulak-Michalak D}, journal={Pharmacol Rep}, volume={67}, number={1}, pages={32-7}}"}}]}